Google Chrome
Safari
Firefox
Edge
Search
Article / Dec 19, 2005
Hovione In Macau: Pharmaceutical ingredient plant is an important part of firm's global network
C&EN, 19 December 2005
Article / Aug 01, 2005
The Future Lies in Partnering
Pharmaceutical Formulation & Quality, August/September 2005
Press Release / Aug 17, 2005
Hovione expands its range of services in Particle Design technology
To address a significant market interest in Advanced APIs (aAPI®), Hovione has increased its range of services and multi-scale facilities in cGMP Spray Drying
Press Release / Aug 01, 2005
Hovione Group sales grow 8% for fiscal year 2004/05
Hovione announces that the consolidated sales volume for the fiscal year ended 31st March 2005 amounted to US$81.4 million, representing a growth of 8% over the previous year.
Article / Jul 27, 2006
Controversy Surrounds Europe’s New Pharma Manufacturing Law
Chemical Week, 27 July 2005
Press Release / Jun 16, 2005
Allos Therapeutics and Hovione Enter Into Manufacturing Agreement for EFAPROXYN(TM) Bulk Drug Substance
Allos Therapeutics, Inc. and Hovione announced today that they have entered into a long-term manufacturing agreement for the supply of EFAPROXYN bulk drug substance, efaproxiral sodium.
Press Release / Apr 07, 2005
Hovione stands behind 3 NCE launches
Hovione's commitment to supporting the high risk business of drug development is paying off.